Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial.
Homeopathy is a complementary and integrative medicine used in depression, The aim of this study is to investigate the non-inferiority and tolerability of individualized homeopathic medicines [Quinquagintamillesmial (Q-potencies)] in acute depression, using fluoxetine as active control. Ninety-one outpatients with moderate to severe depression were assigned to receive an individualized homeopathic medicine or fluoxetine 20 mg day(-1) (up to 40 mg day(-1)) in a prospective, randomized, double-blind double-dummy 8-week, single-center trial. Primary efficacy measure was the analysis of the mean change in the Montgomery & Åsberg Depression Rating Scale (MADRS) depression scores, using a non-inferiority test with margin of 1.45. Secondary efficacy outcomes were response and remission rates. Tolerability was assessed with the side effect rating scale of the Scandinavian Society of Psychopharmacology. Mean MADRS scores differences were not significant at the 4th (P = .654) and 8th weeks (P = .965) of treatment. Non-inferiority of homeopathy was indicated because the upper limit of the confidence interval (CI) for mean difference in MADRS change was less than the non-inferiority margin: mean differences (homeopathy-fluoxetine) were -3.04 (95% CI -6.95, 0.86) and -2.4 (95% CI -6.05, 0.77) at 4th and 8th week, respectively. There were no significant differences between the percentages of response or remission rates in both groups. Tolerability: there were no significant differences between the side effects rates, although a higher percentage of patients treated with fluoxetine reported troublesome side effects and there was a trend toward greater treatment interruption for adverse effects in the fluoxetine group. This study illustrates the feasibility of randomized controlled double-blind trials of homeopathy in depression and indicates the non-inferiority of individualized homeopathic Q-potencies as compared to fluoxetine in acute treatment of outpatients with moderate to severe depression.
Adler
U C
UC
Faculdade de Medicina de Jundiaí, Homeopathy Graduation Programme, Department of Psychobiology, Universidade Federal de São Paulo, R. Napoleão de Barros, 925 São Paulo, SP 04024-002, Brazil.
Paiva
N M P
NM
Cesar
A T
AT
Adler
M S
MS
Molina
A
A
Padula
A E
AE
Calil
H M
HM
J Clin Psychopharmacol. 2007 Apr;27(2):177-81
17414242
Br J Psychiatry. 1987 Jun;150:797-800
3651734
Acta Psychiatr Scand Suppl. 1987;334:1-100
2887090
J Consult Clin Psychol. 2006 Feb;74(1):112-20
16551148
Eur Neuropsychopharmacol. 2006 Dec;16(8):601-11
16769204
Cad Saude Publica. 2005;21 Suppl:43-53
16462996
Arch Gen Psychiatry. 1992 Aug;49(8):624-9
1637252
JAMA. 2003 Jun 18;289(23):3152-60
12813121
Pharmacol Ther. 2007 Jan;113(1):134-53
17010443
Rheumatology (Oxford). 2004 May;43(5):577-82
14734789
J Affect Disord. 2003 Sep;76(1-3):127-35
12943942
PLoS Med. 2008 Feb;5(2):e45
18303940
Pharmacopsychiatry. 2006 Mar;39(2):66-75
16555167
BMC Fam Pract. 2004 Sep 07;5:19
15353006
J Clin Psychiatry. 1999 Dec;60(12):824-30
10665628
Homeopathy. 2005 Jul;94(3):141-4
16060199
J Affect Disord. 2003 Dec;77(3):255-60
14612225
Adv Data. 2004 May 27;(343):1-19
15188733
J Clin Psychiatry. 2003 Mar;64(3):282-7
12716269
Am J Med. 2000 Jan;108(1):54-64
11059441
Expert Rev Neurother. 2006 Nov;6(11):1741-51
17144787
Br J Psychiatry. 2004 Nov;185:372-7
15516544
J Clin Epidemiol. 2008 Dec;61(12):1197-1204
18834714
J Affect Disord. 2007 Jan;97(1-3):23-35
16926053
Psychiatry Clin Neurosci. 2007 Jun;61(3):295-307
17472599
J Clin Psychopharmacol. 2002 Feb;22(1):40-5
11799341
Fam Pract. 2003 Dec;20(6):685-9
14701893
J Clin Psychiatry. 2007 Jun;68(6):935-40
17592920
Eur J Pediatr. 2005 Dec;164(12):758-67
16047154
Cad Saude Publica. 2007 Mar;23(3):565-74
17334571
Homeopathy. 2005 Jul;94(3):145-52
16060200
BMC Complement Altern Med. 2006 Nov 13;6:37
17101037
Lancet. 2005 Aug 27-Sep 2;366(9487):726-32
16125589
JAMA. 2006 Mar 8;295(10):1152-60
16522836
Homeopathy. 2005 Jul;94(3):153-63
16060201